News & Media

Learn what’s new at Wheeler Bio

Filter By

All Articles Blogs Events News + PR Resources Videos

Resources

Podcast: From Development to Manufacturing in Biologics

June 6, 2023

News + PR

Wheeler Bio Appoints Dr. Stewart McNaull as Chief Business Officer

June 6, 2023

News + PR

Wheeler Bio and Charles River Laboratories Announce Agreement to Build and Operate RightSource^SM Laboratory

May 31, 2023

Blogs

Shortening mAb development timelines with accelerative CMC strategies

May 25, 2023

News + PR

Wheeler Bio Announces Closing of $31 Million Series A Round Supporting its Clinical (CGMP) Drug Substance Manufacturing Facility in Oklahoma City

April 13, 2023

News + PR

Wheeler Bio Licenses ATUM’s Proprietary Leap-In Transposase® Technology in Support of its Disruptive CDMO Service Offering

December 14, 2022

News + PR

Alloy Therapeutics and Echo Investment Capital Create Wheeler Bio to Accelerate the Development of New Antibody Therapeutics

August 12, 2022

Articles

Reducing Time to IND, Increasing Quality, and Building Trust Through Shared Data

August 5, 2022

Articles

Applying an Advanced Pharma 4.0 Perspective to Design the Facility of the Future

August 5, 2022

News + PR

Wheeler Bio Announces $14M Seed Round To Expand Access To Portable CMC™

August 4, 2022

Our Expert Team

Let’s Get Started

Wheeler is excited to collaborate on the path to accelerated clinical impact. Whether you’re an Innovator, a CRO, or a CDMO, we want to hear from you.